Home/Medications/Wegovy®
Injectable

Wegovy®

semaglutide injection

The FDA-approved weekly injection for chronic weight management.

15%
Avg. Weight Loss
FDA
Approved
weekly
Injection
Wegovy® (semaglutide injection) — FDA-approved GLP-1 injection for weight loss

FDA Approved

Clinically Proven

15%

Avg. Weight Loss

What is Wegovy®?

Wegovy® is an FDA-approved prescription injection for adults with obesity or overweight with weight-related medical problems. It's a once-weekly injection of semaglutide that helps regulate appetite and food intake.

FDA-Approved / FDA-Registered Pharmacy

How It Works

Semaglutide mimics a hormone called GLP-1 that targets areas of the brain involved in appetite regulation. This helps you feel fuller longer, reduces hunger, and decreases food cravings.

Key Mechanism:

"Mimics natural hormones to reduce appetite, increase feelings of fullness after meals, and regulate metabolism."

The Medication

Meet Wegovy®

Wegovy® complete medication kit from Novo Nordisk — shipped via NovoCare
Semaglutide

Once weekly

Wegovy® close-up showing injection device detail

Inside the Package

4 pen injectors

Wegovy® delivery packaging from NovoCare — shipped directly by Novo Nordisk

Delivered via NovoCare

Ships from Novo Nordisk

Once weekly

Single weekly injection

Proven Results

15% avg. weight loss

Via NovoCare

Ships from manufacturer

Requires Refrigeration

Cold-chain shipping included

Real Results

Transformations that inspire.

Join thousands who've achieved sustainable weight loss with Imbue.

Patient who lost 47 lbs in 5 months with Wegovy® GLP-1 weight loss medication

-47 lbs

5 months

Patient who lost 55 lbs in 6 months with Wegovy® GLP-1 weight loss medication

-55 lbs

6 months

Patient who lost 62 lbs in 7 months with Wegovy® GLP-1 weight loss medication

-62 lbs

7 months

*Individual results may vary. These patients combined medication with lifestyle changes.

STEP Program

Clinical Results

15%

average body weight loss

Duration

68 weeks

Participants

16,000+

Key Finding:

85% of patients maintained weight loss at 2 years in extended trials

SELECT trial showed 20% reduction in major cardiovascular events

Important Note

"Results may vary. Weight loss is a journey and individual results depend on adherence to treatment, starting weight, and biological response."

Dosing Information

Designed for simplicity and effectiveness. Your provider will guide your specific dosing schedule.

Frequency

Once weekly

Instructions

Inject under the skin of your stomach, thigh, or upper arm on the same day each week

Titration

Start at 0.25mg, increasing every 4 weeks to maintenance dose of 2.4mg

Side Effects

Common Side Effects

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Injection site reactions

Most side effects are mild and improve as your body adjusts to the medication.

Serious Side Effects

  • Thyroid tumors (boxed warning)
  • Pancreatitis
  • Gallbladder disease
  • Acute kidney injury

Who Is This For?

Our medications are prescribed for individuals who meet specific medical criteria.

BMI Requirement

Adults with BMI ≥30 (obesity) or BMI ≥27 (overweight) with at least one weight-related condition.

Commitment

Individuals ready to combine medication with lifestyle changes for long-term weight success.

Best For

Patients who prefer the simplicity of once-weekly dosing with the most extensive long-term safety and efficacy data of any GLP-1 for weight loss. Backed by the STEP trials and the SELECT cardiovascular outcomes study.

Who should NOT take this

Do not take if you have a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or are pregnant/breastfeeding.

Simple, Transparent Pricing

HSA / FSA ELIGIBLE

Total Monthly Cost

$228/month

$29/mo

Membership

+

$199/mo

Medication

  • Licensed physician consultations & monitoring
  • Dosage adjustments & prescription renewals
  • Medication shipped direct from NovoCare
  • No contracts — cancel anytime

Starting price. Medication cost may vary by dosage as you titrate up.

Get Started with Wegovy®

Wegovy® at $199/month through NovoCare is comparable to compounded semaglutide pricing ($200–400/month) — but backed by 16,000+ patient clinical trials and FDA approval.

Frequently Asked Questions

Ready to get started?

Begin your weight loss journey today with Wegovy®. Our providers are ready to support you.